Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EBS
EBS logo

EBS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Emergent BioSolutions Inc (EBS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
7.930
1 Day change
-3.41%
52 Week Range
14.060
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

EBS is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has short-term technical strength, but the setup is not compelling enough to call an outright buy: there is no AI Stock Picker or SwingMax buy signal, analysts have trimmed price targets after an earnings miss, insiders are selling aggressively, and there is no recent news catalyst. My direct view: hold and wait rather than buy immediately.

Technical Analysis

EBS is trading at 9.22, slightly above the previous close of 9.18, with the stock showing a modest short-term rebound. MACD histogram is positive and expanding, which supports near-term momentum. However, RSI_6 at 72.023 is elevated, suggesting the move may be extended. Moving averages are converging, which usually indicates a neutral-to-transition phase rather than a strong confirmed uptrend. Key levels: pivot 8.591, resistance 9.16 and 9.511, support 8.021 and 7.67. Price is already near first resistance, so upside from here looks limited without a fresh catalyst.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is strongly bullish on balance. The very low put-call ratios imply call-heavy positioning, while today's volume is also heavily skewed to calls (869 calls vs 16 puts). Open interest is high at 13,925 today versus 11,936 call open interest and 1,989 put open interest, reinforcing bullish sentiment. However, implied volatility is elevated at 65.2, and volume is well above the 30-day average, showing active speculative interest rather than a clean long-term accumulation signal.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
5

Positive Catalysts

  • ["Positive MACD momentum with the histogram expanding above zero", "Bullish options positioning with very low put-call ratios", "H.C. Wainwright still maintains a Buy rating despite lowering the target"]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no fresh event-driven catalyst", "Analyst price target cut to $12 from $15 after an earnings miss", "Insiders are selling, and selling activity increased 140.86% over the last month", "No recent AI Stock Picker signal", "No recent SwingMax signal", "Price is approaching resistance, limiting immediate upside"]

Financial Performance

No usable latest-quarter financial snapshot was provided due to an error, so there is no confirmed quarter-over-quarter financial data to assess. The only direct financial takeaway in the dataset is that the company recently posted an earnings miss, which led to a lowered analyst price target. For a long-term beginner investor, the lack of clear financial growth data makes the stock harder to justify as an immediate buy.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Wall Street sentiment is mixed-to-positive but weakening. H.C. Wainwright lowered its price target to $12 from $15 while keeping a Buy rating, which shows continued optimism but reduced conviction after the earnings miss. The pros view is that analysts still see upside from current levels. The cons view is that target cuts, weak earnings, and insider selling suggest deteriorating confidence. Overall, analysts are still constructive, but the direction of revisions is negative.

Wall Street analysts forecast EBS stock price to rise
1 Analyst Rating
Wall Street analysts forecast EBS stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 8.210
sliders
Low
15
Averages
15
High
15
Current: 8.210
sliders
Low
15
Averages
15
High
15
H.C. Wainwright
Buy
downgrade
$15 -> $12
AI Analysis
2026-03-09
Reason
H.C. Wainwright
Price Target
$15 -> $12
AI Analysis
2026-03-09
downgrade
Buy
Reason
H.C. Wainwright lowered the firm's price target on Emergent BioSolutions to $12 from $15 and keeps a Buy rating on the shares following the earnings miss. The firm cites lowered earnings expectations for the target cut.
JPMorgan
NULL -> Overweight
maintain
2025-12-02
Reason
JPMorgan
Price Target
2025-12-02
maintain
NULL -> Overweight
Reason
JPMorgan raised the firm's price target on Erste Group Bank to EUR 107 from EUR 102 and keeps an Overweight rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EBS
Unlock Now

People Also Watch